Modulation of Acute Myeloblastic Leukemia (AML) Cell Proliferation and Blast Colony Formation by Antisense Oligomer for IL-1 Beta Converting Enzyme (ICE) and IL-1 Receptor Antagonist (IL-1ra)
Authors:
- S. Stošić-GrujičićSSS. Stošić-Grujičić
- N. BasaraNBN. Basara
- P. MilenkovićPMP. Milenković
- C.A. DinarelloCDC.A. Dinarello
- 1 January 1995
- journal article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 7 (1) , 67-70
Abstract
In the present study we investigated the effects of IL-1 antagonism on the autonomous growth of cells in acute myeloblastic leukemia (AML). To examine the role of pro-IL-1 processing, antisense technology was employed with 16-mer phosphorothioate oligodeoxynucleotide directed against human IL-1 beta converting enzyme (ICR) in 7 randomly selected AML cases. The addition of 10-75 microM of antisense oligonucleotide (but not of control oligonucleotide) significantly inhibited spontaneous proliferation of bone marrow- (BM) and peripheral blood- (PB) derived low density leukemic cells in a dose-dependent way. Similarly, spontaneous as well as induced CFU-AML colony formation was inhibited by human ICE antisense oligonucleotide with sample-to-sample variability. In separate experiments, in order to examine the effects of blockade of endogenously produced IL-1 to IL-1 receptors, the functional activity of human recombinant IL-1 receptor antagonist (IL-1ra) was tested. Continuous exposure to high concentrations of IL-1ra (up to 100 micrograms/ml) produced dose-dependent inhibition of spontaneous proliferation of the BM-derived blast cells from 9 of the 14 patients and of the PB-derived cells from 10 of the 14 patients. However, in some of these patients, the lower IL-1ra doses (down to 100 ng/ml) induced potentiation of spontaneous proliferation, suggesting a novel regulatory pathway for IL-1 receptor engagement. Similar results were obtained on CFU-AML colony formation, showing inhibition at higher IL-1ra doses, but in a few AML cases stimulatory effect at lower IL-1ra doses.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 5 references indexed in Scilit:
- Molecular Cloning of the Interleukin-1β Converting EnzymeScience, 1992
- Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cellsBlood, 1991
- Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells.Proceedings of the National Academy of Sciences, 1989
- Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.Journal of Experimental Medicine, 1987
- Granulopoietic differentiation in AML blasts in cultureBlood, 1981